Asthma in Patients With Japanese Cedar Pollinosis [PDF]
Japanese cedar pollen is the most common causative allergen for seasonal allergic rhinitis (AR) in Japan. More commonly known as Japanese cedar pollinosis, it occurs in spring causing the typical symptoms of seasonal AR, such as sneezing, rhinorrhea ...
Akihiko Tanaka +3 more
doaj +5 more sources
Sublingual Immunotherapy for Japanese Cedar Pollinosis: Current Clinical and Research Status [PDF]
The incidence of Japanese cedar pollinosis is increasing significantly in Japan, and a recent survey suggested that about 40% of the population will develop this disease. However, spontaneous remission is rare.
Daiju Sakurai +5 more
doaj +2 more sources
Complement Factor H Is an Early Predictive Biomarker of the Therapeutic Efficacy of Sublingual Immunotherapy for Japanese Cedar Pollinosis [PDF]
Sublingual immunotherapy for Japanese cedar pollinosis can improve the symptoms of allergic rhinitis and modify its natural course. However, sublingual immunotherapy requires a long treatment period and some patients do not respond to treatment.
Riyo Yoneda +8 more
doaj +2 more sources
Effects of citrus juice fermented with Lactobacillus plantarum YIT 0132 on Japanese cedar pollinosis during probiotic consumption: an open study. [PDF]
ABSTRACTJapanese cedar pollinosis (JCPsis) is a major national health problem in Japan. The present review provides an update on information on JCPsis based on clinical data from our research group, through the support of the Department of Health and Welfare (Japanese Government), during the period from 1988 to 1997, because this disease is ...
Kakiyama S +3 more
europepmc +3 more sources
Allergen‐specific subcutaneous immunotherapy for Japanese cedar pollinosis decreases the number of metachromatic cells and eosinophils in nasal swabs during the preseason and in season [PDF]
Background and objective Nasal symptoms of allergic rhinitis can be reduced with allergen‐specific subcutaneous immunotherapy (SCIT). However, the mechanisms underlying the effectiveness of SCIT for Japanese cedar pollinosis are not well understood.
Kuninori Otsuka +3 more
doaj +2 more sources
Next-Generation Allergen-Specific Immunotherapy for Japanese Cedar Pollinosis Using Molecular Approaches [PDF]
Fumio Takaiwa1,2 1Soul Signal Institute, Kojyohama, Shiraoi, Hokkaido, 059-0641, Japan; 2Institute of Agrobiological Sciences, National Agriculture and Food Research Organization, Tsukuba, Ibaraki, 305-8602, JapanCorrespondence: Fumio TakaiwaInstitute of
Takaiwa F
doaj +2 more sources
Efficacy of dual sublingual immunotherapy with Japanese cedar pollen and house dust mite allergens in patients with allergic rhinitis sensitized to multiple allergens [PDF]
Objective: In the present study, we examined the effects of dual sublingual immunotherapy (SLIT) with Japanese cedar pollen (JCP) and house dust mite (HDM) allergens on nasal symptoms during the peak pollen period (PPP) and in late fall (LF) in patients ...
Fujii, Tatsuya +4 more
core +2 more sources
Decreased numbers of metachromatic cells in nasal swabs in Japanese cedar pollinosis following sublingual immunotherapy [PDF]
Background and Objective Nasal symptoms were reduced following allergen‐specific sublingual immunotherapy (SLIT) for allergic rhinitis. The mechanisms underlying the effectiveness of SLIT for Japanese cedar pollinosis are poorly understood.
Kuninori Otsuka +3 more
doaj +2 more sources
Japanese cedar pollinosis: discovery, nomenclature, and epidemiological trends. [PDF]
The history of pollinosis in Japan before the discovery of Japanese cedar pollinosis was presented in part I in this paper. Until early 1960s, it was believed that there was no pollinosis in Japan except one case of ragweed pollinosis. The summary of how the Japanese cedar pollinosis was discovered and named was presented in part II, by referring to ...
Saito Y.
europepmc +3 more sources
Real-Life Safety of Japanese Cedar Pollen Sublingual Immunotherapy Tablets: A Post-Marketing Survey. [PDF]
We assessed the incidence of adverse drug reactions and effectiveness through two seasons of daily Japanese cedar (JC) pollen SLIT‐tablets 5000 JAU in Japan. Real‐life safety and effectiveness of JC pollen SLIT‐tablets appeared in patients with JC‐pollinosis.
Gotoh M +5 more
europepmc +2 more sources

